A detailed history of Barclays PLC transactions in Inari Medical, Inc. stock. As of the latest transaction made, Barclays PLC holds 97,141 shares of NARI stock, worth $7.77 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
97,141
Previous 288,079 66.28%
Holding current value
$7.77 Million
Previous $11.9 Million 58.26%
% of portfolio
0.0%
Previous 0.0%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 13, 2025

SELL
$40.61 - $58.21 $7.75 Million - $11.1 Million
-190,938 Reduced 66.28%
97,141 $4.96 Million
Q3 2024

Nov 15, 2024

BUY
$40.68 - $58.62 $1.03 Million - $1.49 Million
25,365 Added 9.65%
288,079 $11.9 Million
Q2 2024

Aug 14, 2024

SELL
$37.11 - $50.69 $6.02 Million - $8.22 Million
-162,215 Reduced 38.17%
262,714 $12.7 Million
Q1 2024

May 15, 2024

BUY
$40.65 - $65.76 $12.5 Million - $20.2 Million
306,994 Added 260.31%
424,929 $20.4 Million
Q4 2023

Feb 15, 2024

SELL
$48.3 - $68.06 $6.38 Million - $8.99 Million
-132,127 Reduced 52.84%
117,935 $7.66 Million
Q3 2023

Nov 07, 2023

BUY
$54.2 - $71.67 $505,035 - $667,821
9,318 Added 3.87%
250,062 $16.4 Million
Q2 2023

Aug 03, 2023

BUY
$56.23 - $71.17 $8.31 Million - $10.5 Million
147,828 Added 159.1%
240,744 $14 Million
Q1 2023

May 04, 2023

BUY
$53.43 - $68.12 $3.84 Million - $4.9 Million
71,940 Added 342.96%
92,916 $5.74 Million
Q4 2022

Feb 13, 2023

SELL
$61.23 - $83.62 $786,070 - $1.07 Million
-12,838 Reduced 37.97%
20,976 $1.33 Million
Q3 2022

Nov 03, 2022

BUY
$65.58 - $84.69 $1.33 Million - $1.71 Million
20,230 Added 148.93%
33,814 $2.46 Million
Q2 2022

Aug 12, 2022

BUY
$52.13 - $93.81 $242,665 - $436,685
4,655 Added 52.13%
13,584 $924,000
Q1 2022

May 16, 2022

BUY
$64.92 - $99.47 $579,670 - $888,167
8,929 New
8,929 $809,000

Others Institutions Holding NARI

About Inari Medical, Inc.


  • Ticker NARI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 53,389,700
  • Market Cap $4.27B
  • Description
  • Inari Medical, Inc., a medical device company, develops, manufactures, markets, and sells devices for the interventional treatment of venous diseases in the United States. The company provides ClotTriever, a mechanical thrombectomy system, which is designed to core, capture, and remove large clots from large vessels, as well as for treatment of ...
More about NARI
Track This Portfolio

Track Barclays PLC Portfolio

Follow Barclays PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Barclays PLC, based on Form 13F filings with the SEC.

News

Stay updated on Barclays PLC with notifications on news.